Drugs / Methamphetamine
Methamphetamine
Drug Prescription products are available in the U.S.; the drug is a Schedule II controlled substance.CNS stimulant (serotonin-norepinephrine-dopamine releasing agent)
- Registered trials
- 13
- Ongoing
- 3/ 23%
- Completed
- 9
- Indications
- 2
Approved indications
| Indication |
|---|
| ADHD |
| Weight loss (obesity/overweight) |
Clinical trial landscape
13 registered studies reference this molecule or one of its brands. The split below shows how many are ongoing versus completed per phase.
| Phase | Total | Ongoing | Completed | Split |
|---|---|---|---|---|
| Phase 1 | 5 | 0 | 4 | |
| Early Phase 1 | 5 | 1 | 4 | |
| Phase 2 | 2 | 2 | 0 | |
| Not applicable | 1 | 0 | 1 | |
| All phases | 13 | 3 | 9 |
Ongoing Completed Balance withdrawn, terminated, or status unreported.
Study records: ClinicalTrials.gov →
Mechanism of action
Acts as a serotonin-norepinephrine-dopamine releasing agent and CNS stimulant.
Recent developments
Headlines link to the original publisher. Sources limited to a reviewed list of journals, regulators, and medical press.